F16.19

Clinical Causes: Use of illicit hallucinogenic substances such as LSD, psilocybin, mescaline, or DMT. Repeated or excessive consumption of hallucinogens leading to dependency or abuse. Psychological factors like curiosity, peer influence, or mental health issues prompting experimentation. Environmental triggers or social settings that encourage hallucinogen use. Underlying psychiatric conditions that may increase vulnerability to substance abuse.

Key Symptoms: Altered perceptions of reality, including visual or auditory hallucinations. Unusual thought patterns, confusion, or disorganized thinking. Mood swings, anxiety, or episodes of paranoia. Impaired judgment or decreased coordination. Physical effects such as dilated pupils, increased heart rate, or sweating. Potential episodes of psychosis with vivid hallucinations or delusional thinking. Behavioral changes, including agitation or unpredictable actions.

Diagnosis Path: Diagnosis typically involves a detailed evaluation of the patient’s history of substance use, symptom presentation, and physical examination. Healthcare providers employ standardized assessment tools and may perform laboratory tests to rule out other causes of symptoms. The diagnostic process emphasizes identifying hallucinogen abuse that leads to a disorder that affects mental or physical functioning, with no specific hallucinogen being singled out.

Treatment Protocols: Detoxification programs to safely manage withdrawal symptoms if present. Psychotherapy and counseling, such as cognitive-behavioral therapy, to address substance use behaviors. Medication-assisted treatment if co-occurring mental health conditions like anxiety or depression are diagnosed. Support groups and community resources to aid ongoing recovery. Educational programs to prevent relapse and promote healthy lifestyle choices.